Conventional Hip Screws Market Size, Share, & COVID-19 Impact Analysis | Global | 2022-2028 | MedCore | Includes: Titanium Conventional Hip Screws, and 1 more

Overall, the global conventional hip screw market was valued at $184.5 million in 2021. This is expected to decrease over the forecast period at a CAGR of -1.9% to $161.6 million. The full report suite on the global market for conventional hip screws includes titanium and stainless-steel screws.

MARKET REPORT DATA TYPES INCLUDED:

• Unit Sales, Average Selling Prices, Market Size & Growth Trends

• Procedure Numbers

• COVID-19 Impact Analysis

• Market Drivers & Limiters

• Market Forecasts Until 2028, and Historical Data to 2018

• Recent Mergers & Acquisitions

• Company Profiles and Product Portfolios

• Leading Competitors

PROCEDURE NUMBERS

The global conventional hip screw market increased after a down year in 2020 because of the Global COVID-19 pandemic. The market accomplished a recovery in the beginning of 2022, but it is anticipated to see a steady decline in procedure volumes moving forward.

GLOBAL CONVENTIONAL HIP SCREWS MARKET TRENDS

The conventional hip screw market will follow the general trend of the orthopedic trauma market in shifting to the use of titanium as a material. This will buoy some of the negative ASP and unit sales trends in the market.

GLOBAL CONVENTIONAL HIP SCREWS MARKET SHARE INSIGHTS

The global conventional hip screws market has three dominant competitors: DePuy Synthes, Stryker, and Zimmer Biomet. The leading competitor in the conventional hip screw market was DePuy Synthes. DePuy's long-lasting success in the trauma market continues to drive the company's revenue forward as the overall trauma market sees recurrent growth.

GLOBAL CONVENTIONAL HIP SCREW MARKET SEGMENTATION SUMMARY

• Titanium Conventional Hip Screws

• Stainless Steel Conventional Hip Screws

RESEARCH SCOPE SUMMARY

• Regions: North America (Canada, United States)

• Latin America (Argentina, Brazil, Chile, Colombia, Mexico, Peru, Venezuela)

• Western Europe (Austria, Benelux, France, Germany, Italy, Portugal, Scandinavia, Spain, Switzerland, U.K.)

• Central & Eastern Europe (Baltic States, Bulgaria, Croatia, Czech Republic, Greece, Hungary, Kazakhstan, Poland, Romania, Russia, Turkey, Ukraine)

• Middle East (Bahrain, Iran, Israel, Kuwait, Oman, Qatar, Saudi Arabia, United Arab Emirates)

• Asia Pacific (Australia, Cambodia, China, Hong Kong, India, Indonesia, Japan, Malaysia, Myanmar, New Zealand, Philippines, Singapore, South Korea, Taiwan, Thailand, Vietnam)

• Africa (Algeria, Egypt, Ghana, Kenya, Libya, Morocco, Nigeria, South Africa, Sudan, Uganda)

• Base Year: 2021
• Forecast Period: 2022-2028
• Historical Data: 2018-2021

• Quantitative Data: Market Size, Market Share, Market Growth Rates, Units Sold, Average Selling Prices

• Qualitative Data: COVID-19 Impact, Market Growth Trends, Market Limiters, Competitive Analysis & SWOT for Top Competitors, Mergers & Acquisitions, Company Profiles, Product Portfolios

• Data Sources: Primary Interviews with Industry Leaders, Government Physician Data, Regulatory Data, Hospital Private Data, Import & Export Data.

Read more about iData's 9-Step Research Methodology.

WHY CHOOSE IDATA?

Experts Only - iData has been around for over 17 years and is the trusted source of intelligence, and data-driven insights for key industry players. We are made up of specialists with a sole focus on medical devices, dental devices and pharmaceuticals. Our research and consulting field of endeavour never strays from the medical device industry and, because of this, we are the number one choice for leading companies in this field.

Global Coverage - iData's unique methodology, and its expansion to over 70 countries world-wide, has made it one of the most viable sources of intelligence for global companies along with those who plan to expand their portfolio beyond the confines of their own country. Providing procedural data at the country level is another testimony to the trusted global coverage we provide.

Attention to Detail - It's our attention to small details, scheduling of timelines, and keen project management that makes us stand out from the rest. We are creative, and our reports include metrics such as procedure numbers, ASPs, and SKU-level insights that are not found elsewhere.

Pricing - When comparing like-with-like, iData's prices are not only extremely competitive but also the most cost-effective. We strive for success and want the same for our clients. With the level of detail incorporated into each report alongside the extensive segmentation provided, no other report compares at our price point.